MARKET

HCWB

HCWB

Hcw Biologics Inc.
NASDAQ
2.240
-0.190
-7.82%
Pre Market: 2.240 0 0.00% 09:22 09/14 EDT
OPEN
2.430
PREV CLOSE
2.430
HIGH
2.445
LOW
2.160
VOLUME
4.75K
TURNOVER
0
52 WEEK HIGH
36.65
52 WEEK LOW
1.500
MARKET CAP
4.11M
P/E (TTM)
-0.0812
1D
5D
1M
3M
1Y
5Y
1D
Weekly Buzz: JNJ Wins FDA Nod; AXGN, HCWB Strike Deals; ROIV, AZN, GPCR Lead Clinical Trials
NASDAQ · 3d ago
HCW Biologics Updates Special Meeting Proxy Materials
TipRanks · 4d ago
HCW Biologics signs global HCW11-006 distribution deal
TipRanks · 6d ago
HCW Biologics enters exclusive HCW11-006 distribution pact with Akron Biotech
TipRanks · 6d ago
HCW Biologics Signs Agreement With Akron Biotech To Commercialize HCW11-006 To Use As Reagent For New Method Of Human CAR-T Cells Production To Treat Cancer
Benzinga · 6d ago
Weekly Report: what happened at HCWB last week (0831-0904)?
Weekly Report · 09/07 10:06
HCW Biologics receives patent allowance for alopecia areata drug
TipRanks · 09/02 13:20
Weekly Report: what happened at HCWB last week (0824-0828)?
Weekly Report · 08/31 10:12
More
About HCWB
HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The Company is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.

Webull offers Hcw Biologics Inc stock information, including NASDAQ: HCWB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCWB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCWB stock methods without spending real money on the virtual paper trading platform.